MAIA

MAIA Biotechnology, Inc. Common Stock (MAIA)

About MAIA Biotechnology, Inc. Common Stock (MAIA)

MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.

Details

Daily high

$2.04

Daily low

$1.90

Price at open

$2.02

52 Week High

$5.99

52 Week Low

$1.40

Market cap

59.2M

Dividend yield

0.00%

Volume

209,575

Avg. volume

170,725

P/E ratio

-1.80

MAIA Biotechnology, Inc. Common Stock News